Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-2000 | 07-2000 | 04-2000 | 01-2000 | |
| Sales | 1,032,000 | 891,400 | 770,600 | 593,900 |
| Cost of Goods | 513,500 | 442,900 | 407,300 | 315,300 |
| Gross Profit | 518,500 | 448,500 | 363,300 | 278,600 |
| Operating Expenses | -332,100 | 387,600 | 255,400 | 211,500 |
| Operating Income | 851,100 | 61,800 | 108,200 | 67,400 |
| Other Income | -687,400 | 3,300 | 1,055,000 | 1,000 |
| Pre-tax Income | 163,700 | 65,100 | 1,163,200 | 68,400 |
| Income Tax | 76,600 | 55,500 | 444,900 | 15,300 |
| Net Income Continuous | 87,100 | 9,600 | 718,300 | 53,100 |
| Net Income | $87,100 | $9,600 | $718,300 | $53,100 |
| EPS Basic Total Ops | 0.70 | 0.07 | 7.07 | 0.56 |
| EPS Basic Continuous Ops | 0.69 | 0.09 | 7.10 | 0.53 |
| EPS Diluted Total Ops | 0.63 | 0.07 | 6.72 | 0.49 |
| EPS Diluted Continuous Ops | 0.55 | 0.09 | 6.74 | 0.51 |
| EBITDA(a) | $939,600 | $159,200 | $136,300 | $-400 |